Tatva Chintan Pharma Chem reports Q2 FY24 consolidated PAT at Rs. 7.78 Cr
General

Tatva Chintan Pharma Chem reports Q2 FY24 consolidated PAT at Rs. 7.78 Cr

Tatva Chintan Pharma Chem has reported total income of Rs. 97.42 crores during the period ended September 30, 2023

  • By ICN Bureau | November 04, 2023

Tatva Chintan Pharma Chem Ltd has reported Consolidated financial results for the period ended September 30, 2023.

Tatva Chintan Pharma Chem  has posted net profit of Rs. 7.78 crores for the period ended September 30, 2023 as against net profit of Rs. 9.50 crores for the period ended June 30, 2023. The company posted net profit of Rs.7.11 crores for the period ended September 30, 2022.

Tatva Chintan Pharma Chem  has reported total income of Rs. 97.42 crores during the period ended September 30, 2023 as compared to Rs. 115.37 crores during the period ended June 30, 2023. The company reported total income of Rs.92.03 crores during the period ended September 30, 2022. 

For the Half Year ended September 30, 2023, Tatva Chintan Pharma Chem has reported total income of Rs.212.80 crores as compared to Rs.182.31 crores during the 6 months period ended September 30, 2022.

The company has posted net profit of Rs.17.28 crores for the 6 months period ended September 30, 2023 as against net profit of Rs.16.90 crores for the 6 months period ended September 30, 2022.

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Chemical

Petrochemical

Energy

Digitization